[Effects of urinastatin on prevention of cisplatin induced nephrotoxicity].
Sasa
H
H
Department of Obstetrics and Gynecology, National Defense Medical College, Tokorozawa, Japan.
Hisano
A
A
Kudo
K
K
Kuki
E
E
Miyauchi
M
M
Kita
T
T
Kikuchi
Y
Y
Tode
T
T
Furuya
K
K
Nagata
I
I
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006023:Glycoproteins / Q000627:therapeutic use*; D006801:Humans; D007668:Kidney / Q000187:drug effects*; D007674:Kidney Diseases / Q000517:prevention & control*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D006023:Glycoproteins; D004317:Doxorubicin; D003520:Cyclophosphamide; C028665:urinastatin; D002945:Cisplatin